In general, thrombocytopenia due to rheumatic immune diseases is relatively severe and can lead to an increased risk of bleeding, and in severe cases, internal or cranial hemorrhage.
Rheumatic immune diseases such as systemic lupus erythematosus and dry syndrome may all affect the blood system and cause thrombocytopenia. Thrombocytopenia leads to an increased risk of bleeding in the body, which in mild cases may be manifested as skin bleedings, petechiae, bleeding gums, epistaxis (nosebleed), etc. In severe cases, severe symptoms such as vomiting blood, black stools, hematuria, cerebral hemorrhage and other severe symptoms may occur, which may easily be life-threatening.
Thrombocytopenia can be caused by disease activity, new blood system damage, infections, drugs, etc. The principle of treatment is to respond to the cause of the disease. When thrombocytopenia is detected in patients with rheumatic immune diseases, the cause of thrombocytopenia should be clarified as soon as possible according to the medical history and relevant examination results, and corresponding treatment should be provided.
Patients with thrombocytopenia caused by rheumatic immune diseases are advised to go to the rheumatology and immunology department of a regular hospital as soon as possible and follow the doctor’s instructions.